1st Quarter - Termination
W STRATEGIES, LLC for 23ANDME, INC.
Firm
Client
Income
$20,000
Expenses
—
Terminated
Mar 31, 2023
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 20, 2023 | $20,000 | Replaced |
| 1st Quarter - Termination (this page) | Jul 17, 2023 | $20,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues related to regulation of Direct to Consumer (DTC) Genetic Testing, including FDA regulation of DTC tests and privacy in consumer genetics. H.R.4128: VALID Act of 2021. Legislation related to data privacy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.